Gerd Gellissen

Title: Gerd Gellissen: Innovator in Biotechnology

Introduction

Gerd Gellissen is a notable inventor based in Wülfrath, Germany. He has made significant contributions to the field of biotechnology, particularly in the production of heterologous proteins and polypeptides with chorismate mutase activity. His innovative approaches have led to the development of two patents that showcase his expertise and creativity in this domain.

Latest Patents

Gellissen's latest patents include a method for the production of a heterologous protein using yeast-type host cells. This method involves preparing yeast-type host cells that contain both endogenous homologous DNA sequences and recombinant DNA sequences. The process allows for the expression and secretion of heterologous proteins, which are then separated for further use. His second patent relates to a nucleic acid molecule that codes for a polypeptide with chorismate mutase activity. This invention encompasses vectors, host cells, and methods for producing polypeptides, as well as the use of yeast strains for recombinant expression of heterologous genes.

Career Highlights

Throughout his career, Gerd Gellissen has worked with several prominent companies in the biotechnology sector. Notable among these are Artes Biotechnology GmbH and Rhein Biotech Gesellschaft für Neue Biotechnologische Prozesse und Produkte mbH. His work in these organizations has contributed to advancements in biotechnological processes and products.

Collaborations

Gellissen has collaborated with esteemed colleagues such as Jens Klabunde and Cornelis Hollenberg. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Gerd Gellissen's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to impact the production of proteins and polypeptides, showcasing the importance of innovation in scientific research.